Biochemical monitoring of the early endocytic traffic of the type I interferon receptor

Journal of Interferon and Cytokine Research

Volumn 30, Issue 2, 2010, Pages 89-98

  Payelle Brogard, Béatrice ^a   Pellegrini, Sandra ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY ENDOSOME ANTIGEN 1; INTERFERON RECEPTOR; JANUS KINASE; JANUS KINASE 1; PROTEIN KINASE TYK2; STAT PROTEIN;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEOMICS; RECEPTOR BINDING; WESTERN BLOTTING;

BINDING SITES; CELL LINE; ENDOSOMES; HUMANS; INTERFERONS; PROTEIN TRANSPORT; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 77649319880     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0044     Document Type: Article

References (43)

1. Balbis A, Parmar A, Wang Y, Baquiran G, Posner BI. 2007. Compartmentalization of signaling-competent epidermal growth factor receptors in endosomes. Endocrinology 148(6):2944-2954.
2. Barbieri MA, Roberts RL, Gumusboga A, Highf eld H, Alvarez-Dominguez C, Wells A, Stahl PD. 2000. Epidermal growth factor and membrane traff cking. EGF receptor activation of endocyto-sis requires Rab5a. J Cell Biol 151(3):539-550.
3. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6(12):975-990.
4. Breuza L, Halbeisen R, Jeno P, Otte S, Barlowe C, Hong W, Hauri HP. 2004. Proteomics of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identif es ERGIC-32, a new cycling protein that interacts with human Erv46. J Biol Chem 279(45):47242-47253.
5. Colonna M. 2007. TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol 37(2):306-309.
6. Croze E, Usacheva A, Asarnow D, Minshall RD, Perez HD, Colamonici O. 2000. Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specif cally associates with the human type I IFN receptor. J Immunol 165(9):5127-5132.
7. Devergne O, Ghiglione C, Noselli S. 2007. The endocytic control of JAK/STAT signalling in Drosophila. J Cell Sci 120:3457-3464.
8. Du Z, Shen Y, Yang W, Mecklenbrauker I, Neel BG, Ivashkiv LB. 2005. Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway. Proc Natl Acad Sc i USA 102(29):10267-10272.
9. Feng GS, Ouyang YB, Hu DP, Shi ZQ, Gentz R, Ni J. 1996. Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway. J Biol Chem 271(21):12129-12132.
10. Gauthier DJ, Lazure C. 2008. Complementary methods to assist subcellular fractionation in organellar proteomics. Expert Rev Proteomics 5(4):603-617.
11. Giese B, Au-Yeung CK, Herrmann A, Diefenbach S, Haan C, Kuster A, Wortmann SB, Roderburg C, Heinrich PC, Behrmann I, Muller-Newen G. 2003. Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis. J Biol Chem 278(40):39205-39213.
12. Giovannone B, Lee E, Laviola L, Giorgino F, Cleveland KA, Smith RJ. 2003. Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J Biol Chem 278(34):31564-31573.
13. Haglund K, Sigismund S, Polo S, Szymkiewicz I, Di Fiore PP, Dikic I. 2003. Multiple monoubiquitination of RTKs is suff cient for their endocytosis and degradation. Nat Cell Biol 5(5):461-466.
14. Haro T, Shimoda K, Kakumitsu H, Kamezaki K, Numata A, Ishikawa F, Sekine Y, Muromoto R, Matsuda T, Harada M. 2004. Tyrosine kinase 2 interacts with and phosphorylates receptor for activated C kinase-1, a WD motif-containing protein. J Immunol 173(2):1151-1157.
15. Hoeller D, Volarevic S, Dikic I. 2005. Compartmentalization of growth factor receptor signalling. Curr Opin Cell Biol 17(2):107-111.
16. Huber LA, Pfaller K, Vietor I. 2003. Organelle proteomics: implications for subcellular fractionation in proteomics. Circ Res 92(9):962-968.
17. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griff ths E, Krawczyk C, Richardson CD, Aitken K, Iscove N, Koretzky G, Johnson P, Liu P, Rothstein DM, Penninger JM. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409(6818):349-354.
18. Jahn T, Seipel P, Urschel S, Peschel C, Duyster J. 2002. Role for the adaptor protein Grb10 in the activation of Akt. Mol Cell Biol 22(4):979-991.
19. Jaitin DA, Roisman LC, Jaks E, Gavutis M, Piehler J, Van der Heyden J, Uzé G, Schreiber G. 2006. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced af-f nity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol 26(5):1888-1897.
20. Kikuchi M, Hatano N, Yokota S, Shimozawa N, Imanaka T, Taniguchi H. 2004. Proteomic analysis of rat liver peroxisome: presence of peroxisome-specif c isozyme of Lon protease. J Biol Chem 279(1):421-428.
21. Kishimoto T. 1989. The biology of interleukin-6. Blood 74(1):1-10.
22. Kumar KG, Krolewski JJ, Fuchs SY. 2004. Phosphorylation and specif c ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem 279(45):46614-46620.
23. Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY. 2003. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J 22(20):5480-5490.
24. Lekmine F, Sassano A, Uddin S, Majchrzak B, Miura O, Druker BJ, Fish EN, Imamoto A, Platanias LC. 2002. The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. Biochem Biophys Res Commun 291(4):744-750.
25. Li X, Galli T, Leu S, Wade JB, Weinman EJ, Leung G, Cheong A, Louvard D, Donowitz M. 2001. Na+-H+ exchanger 3 (NHE3) is present in lipid rafts in the rabbit ileal brush border: a role for rafts in traff cking and rapid stimulation of NHE3. J Physiol 537(Pt 2):537-552.
26. Ma rc het t i M, Mon ier M N, Fradagrada A, M itc hell K, Bayc hel ier F, Eid P, Johannes L, Lamaze C. 2006. Stat-mediated signaling induced by ty pe I and t ype II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol Biol Cell 17(7):2896-2909.
27. Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, Pellegrini S. 2006. TYK2 activity promotes ligand-induced IFNAR1 proteol-ysis. Biochem J 397(1):31-38.
28. Marijanovic Z, Ragimbeau J, van der Heyden J, Uzé G, Pellegrini S. 2007. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem J 407(1):141-151.
29. Merlin G, Falcoff E, Aguet M. 1985. 125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data. J Gen Virol 66(Pt 5):1149-1152.
30. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375-386.
31. Polo S, Di Fiore PP. 2006. Endocytosis conducts the cell signaling orchestra. Cell 124(5):897-900.
32. Rakemann T, Niehof M, Kubicka S, Fischer M, Manns MP, Rose-John S, Trautwein C. 1999. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro. J Biol Chem 274(3):1257-1266.
33. Rani MR, Ransohoff RM. 2005. Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J Interferon Cytokine Res 25(12):788-798.
34. Sadowski L, Pilecka I, Miaczynska M. 2009. Signaling from endosomes: location makes a difference. Exp Cell Res 315(9): 1601-1609.
35. Saleh AZM, Fang AT, Allison EA, Neupane D, El Fiky AE, Krolewski JJ. 2004. Regulated proteolysis of the IFNAR2 subunit of the interferon-alpha receptor. Oncogene 23:7076-7086.
36. Simonsen A, Lippe R, Christoforidis S, Gaullier JM, Brech A, Callaghan J, Toh BH, Murphy C, Zerial M, Stenmark H. 1998. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 394(6692):494-498.
37. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
38. Teis D, Wunderlich W, Huber LA. 2002. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell 3(6): 803-814.
39. Usacheva A, Smith R, Minshall R, Baida G, Seng S, Croze E, Colamonici O. 2001. The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor. J Biol Chem 276(25):22948-22953.
40. Usacheva A, Tian X, Sandoval R, Salvi D, Levy D, Colamonici OR. 2003. The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex. J Immunol 171(6):2989-2994.
41. Uzé G, Schreiber G, Piehler J, Pellegrini S. 2007. The receptor of the type I interferon family. Curr Top Microbiol Immunol 316:71-95.
42. van Boxel-Dezaire AH, Rani MR, Stark GR. 2006. Complex modulation of cell type-specif c signaling in response to type I interferons. Immunity 25(3):361-372.
43. Wunderlich W, Fialka I, Teis D, Alpi A, Pfeifer A, Parton RG, Lottspeich F, Huber LA. 2001. A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endo-somal/lysosomal compartment. J Cell Biol 152(4):765-776.